Birchview Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Birchview Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$984K	–	54
2023 Q2	$984K	Hold	25,000	–	–	0.74%	25
2023 Q1	$608K	Hold	25,000	–	–	0.48%	30
2022 Q4	$535K	Hold	25,000	–	–	0.38%	32
2022 Q3	$449K	Buy	25,000 +10,000	+67%	+$131K	0.32%	40
2022 Q2	$144K	Hold	15,000	–	–	0.1%	53
2022 Q1	$252K	Hold	15,000	–	–	0.18%	54
2021 Q4	$251K	Hold	15,000	–	–	0.16%	57
2021 Q3	$244K	Buy	+15,000	New	+$163K	0.17%	57

Birchview Capital's ISEE Position: Q3 2023 in Review

Birchview Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 25,000 shares — an estimated $984K sold.

Birchview Capital first reported a position in ISEE in Q3 2021 and held it in 8 quarters. The position peaked at $984K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Birchview Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Birchview Capital sold 25,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $984K.
Birchview Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Birchview Capital's IVERIC bio, Inc. Common Stock position peaked at $984K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Birchview Capital's 13F filing for Q3 2023, filed 14 Nov 2023.